HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates

Item
http://www.wikidata.org/entity/Q34537743
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenAn HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.The Impacts of Genome-wide Analyses on our Understanding of Human Herpesvirus Diversity and Evolution.Pharmacological Induction of Heme Oxygenase-1 Impairs Nuclear Accumulation of Herpes Simplex Virus Capsids upon Infection.US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation.Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.An HSV-2 single-cycle candidate vaccine deleted in glycoprotein D, ΔgD-2, protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2.Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
P2860

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates

Item
http://www.wikidata.org/entity/Q34537743
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@ast
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@en
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@nl
type
label
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@ast
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@en
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@nl
prefLabel
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@ast
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@en
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@nl
P1433
P1476
P2093
P2860
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
@en
P2093
P2860
P31
P356
P433
P478
P50
P577
P698
P921
P932